Placebo

(Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease, researchers said...

(Reuters) - AcelRX Pharmaceuticals Inc said its experimental treatment for post-operative pain met its main goal in a late-stage trial of patients who had undergone knee or hip replacement surgery, sending its shares up 15 percent. AcelRX said its...

WASHINGTON (Reuters) - Merck & Co's experimental insomnia drug suvorexant appears generally effective, according to reviewers at the U.S. Food and Drug Administration, but they questioned the company's proposed dosing levels. The reviewers posted their...

(Reuters) - XenoPort Inc said it would stop development of an experimental multiple sclerosis treatment it planned to launch in 2015 after a late-stage trial failed to show significant improvement over a placebo. Shares of the company fell 26 percent...

Veterinarian Kevin Fitzgerald has an article in the May/June issue of AKC Family Dog magazine titled “Kennel Concerns and Laser Therapy.” I selected the laser therapy segment because it concerns pain therapy and everyone is interested in...

Dear Pharmacist: I've had migraine headaches for 11 years and live on triptan drugs and ibuprofen. There must be something else I can do. Please lend some sensible Suzy insight. — J.C., Tucson, Ariz. Dear J.C.: The sensible thing for me to do is...

NEW YORK (Reuters Health) - Adding a plant-derived compound called a sterol to the cholesterol-lowering agent red yeast rice doesn't make it work any better, according to a new study. "I expected to see a synergistic effect with red yeast rice, and I was...

NEW YORK (Reuters Health) - Women taking a Chinese herbal formula experienced less than half the number of menopausal hot flashes they had before the treatment, according to a new study from Hong Kong. Among women taking an herbal mix called Er-xian...

Baxter International Inc. said Tuesday that a late-stage clinical trial of a plasma product it was testing to treat patients with Alzheimer's disease failed to slow cognitive decline and preserve physical function, sending its shares down more than 3...

When the president and CEO of Boehringer Ingelheim USA starts to talk about the company's most dramatic failure in the last five years, a certain sheepish tone creeps into his voice. He thinks he's going to have to explain the disease the drug was...

AbbVie said Tuesday that it is teaming up with a California drug company to develop an oral treatment for celiac disease. Celiac disease is the most common autoimmune disease, affecting about 6 million people in the U.S. and Europe.  Those affected can'...

NEW YORK (Reuters Health) - Fish oil supplements did not prevent heart problems in people who hadn't had a heart attack yet, in a large long-term study from Italy. The study - a gold-standard randomized, controlled trial - tested the effect of omega-3...